Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial

por Salvi, Sundeep, Balki, Akash, Krishnamurthy, Srikanth, Panchal, Sagar, Patil, Saiprasad, Kodgule, Rahul, Khandagale, Hitesh, Pendse, Amol, Wu, Wen, Rangwala, Shabbir, Tandon, Monika, Barkate, Hanmant
Publicado 2021

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD

por Salvi, Sundeep, Jain, Manish K., Krishnamurthy, Srikanth, Balki, Akash, Kodgule, Rahul, Tandon, Monika, Bhagat, Sagar, Panchal, Sagar, Khatri, Nishtha, Wu, Wen, Pendse, Amol, Patil, Saiprasad, Barkate, Hanmant
Publicado 2022

Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting

por Reddy, Pavan Kumar, Patil, Saiprasad, Khobragade, Akash, Balki, Akash, Raj, Aneesh, Kalikar, Mrunalini, Reddy, Raghavendra, Shinde, Ravindra, CR, Jayanthi, Mutha, Abhinandan, Boyilla, Nagaraju, Rajadhyaksha, Girish C, Karnik, Niteen, Bhagat, Sagar, Pendse, Amol, Dhage, Priyanka, Wu, Wen, Rangwala, Shabbir, Barkate, Hanmant
Publicado 2022